Cumberland Pharmaceuticals Inc. (CPIX)

CPIX Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	39.95	36.54	37.51	40.68	35.05	35.84
Other Revenue	1.33	1.33	2.04	1.33	0.94	1.6
Revenue	41.28	37.87	39.55	42.01	35.99	37.44
Revenue Growth (YoY)	12.21%	-4.26%	-5.85%	16.75%	-3.89%	8.88%
Cost of Revenue	6.4	6.59	6.07	9.12	8.81	8.65
Gross Profit	34.88	31.28	33.49	32.89	27.17	28.79
Selling, General & Admin	28.35	28.15	29.1	26.84	24.8	24.96
Research & Development	5.31	4.82	5.83	6.69	5.68	5.77
Amortization of Goodwill & Intangibles	4.48	4.75	4.76	5.07	4.37	4.43
Operating Expenses	38.14	37.71	39.7	38.6	34.85	35.17
Operating Income	-3.26	-6.43	-6.21	-5.7	-7.68	-6.38
Interest Expense	-0.61	-0.61	-0.67	-0.59	-0.1	-0.26
Interest & Investment Income	0.49	0.33	0.29	0.1	0.03	0.08
Other Non Operating Income (Expenses)	-	-	3.3	-	-	-
EBT Excluding Unusual Items	-3.38	-6.7	-3.29	-6.19	-7.75	-6.57
Asset Writedown	-	-	-3.34	-	-	-
Other Unusual Items	-	-	-	-	2.19	-
Pretax Income	-3.38	-6.47	-6.28	-5.58	-5.56	-6.57
Income Tax Expense	-0.04	-0.02	0.05	0.07	0.03	0.06
Earnings From Continuing Operations	-3.34	-6.44	-6.33	-5.65	-5.6	-6.63
Earnings From Discontinued Operations	-	-	-	-	1.99	3.21
Net Income to Company	-3.34	-6.44	-6.33	-5.65	-3.6	-3.42
Minority Interest in Earnings	0.01	-0.04	0.05	0.08	0.1	0.08
Net Income	-3.33	-6.48	-6.28	-5.57	-3.51	-3.34
Net Income to Common	-3.33	-6.48	-6.28	-5.57	-3.51	-3.34
Shares Outstanding (Basic)	15	14	14	15	15	15
Shares Outstanding (Diluted)	15	14	14	15	15	15
Shares Change (YoY)	4.26%	-1.67%	-1.82%	-2.29%	-1.70%	-1.52%
EPS (Basic)	-0.23	-0.46	-0.44	-0.38	-0.24	-0.22
EPS (Diluted)	-0.23	-0.46	-0.44	-0.38	-0.24	-0.22
Free Cash Flow	6.73	-0.68	5.81	8.35	6.24	5.27
Free Cash Flow Per Share	0.46	-0.05	0.41	0.57	0.42	0.35
Gross Margin	84.49%	82.61%	84.66%	78.30%	75.51%	76.89%
Operating Margin	-7.90%	-16.99%	-15.70%	-13.58%	-21.34%	-17.04%
Profit Margin	-8.06%	-17.11%	-15.88%	-13.26%	-9.75%	-8.92%
Free Cash Flow Margin	16.31%	-1.79%	14.70%	19.88%	17.34%	14.09%
EBITDA	1.34	-1.53	-1.27	-0.38	-3.07	-1.63
EBITDA Margin	3.24%	-4.04%	-3.22%	-0.90%	-8.53%	-4.36%
D&A For EBITDA	4.6	4.9	4.94	5.33	4.61	4.75
EBIT	-3.26	-6.43	-6.21	-5.7	-7.68	-6.38
EBIT Margin	-7.90%	-16.99%	-15.70%	-13.58%	-21.34%	-17.04%
Revenue as Reported	37.87	37.87	39.55	42.01	35.99	37.44
Advertising Expenses	-	2.99	2.9	2.93	1.93	2.38

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q